Paper4787619
Animal scale-up.
Dedrick RL. J Pharmacokinet Biopharm, 1973. Cited by 316 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Animal scale-up. Papers, record 4787619. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4787619
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Models, Biological | Major topic |
| Animals | |
| Biological Transport | |
| Biotransformation | |
| Body Weight | |
| Chlorides | |
| Cytarabine | |
| Dialysis | |
| Diffusion | |
| Humans | |
| Kinetics | |
| Mammals | |
| Methotrexate | |
| Organ Specificity | |
| Pharmaceutical Preparations | |
| Pharmacology | |
| Species Specificity | |
| Thermodynamics | |
| Thiopental | |
| Time Factors |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 2 | 13,804,623 | The importance of dissociaton constant and lipid-solubility in influencing the passage of drugs into the cerebrospinal fluid. | J Pharmacol Exp Ther | 1960 | https://conductscience.org/library/papers/13804623 | PubMed |
| 3 | 5,240,361 | Relationships among area under serum concentration curve, dose, and half-life for novobiocin administered in combination with tetracycline. | J Clin Pharmacol J New Drugs | 1968 | https://conductscience.org/library/papers/5240361 | PubMed |
| 4 | 4,956,026 | Studies of the enzymatic deamination of cytosine arabinoside. I. Enzyme distribution and species specificity. | Biochem Pharmacol | 1965 | https://conductscience.org/library/papers/4956026 | PubMed |
| 5 | 5,677,337 | Thiopental pharmacokinetics. | J Pharm Sci | 1968 | https://conductscience.org/library/papers/5677337 | PubMed |
| 6 | 6,061,556 | Studies of the enzymatic deamination of cytosine arabinoside. 3. Substrate requirements and inhibitors of the deaminase of human liver. | Biochem Pharmacol | 1967 | https://conductscience.org/library/papers/6061556 | PubMed |
| 7 | 6,028,770 | Some pharmacological consequences of species variation in rates of metabolism. | Fed Proc | 1967 | https://conductscience.org/library/papers/6028770 | PubMed |
| 8 | 4,964,068 | Studies of the enzymatic deamination of cytosine arabinoside. II. Properties of the deaminase of human liver. | Biochem Pharmacol | 1967 | https://conductscience.org/library/papers/4964068 | PubMed |
| 9 | 4,983,317 | Comparative drug metabolism. | Prog Drug Res | 1969 | https://conductscience.org/library/papers/4983317 | PubMed |
| 10 | 4,980,116 | A useful thin-layer chromatography method for the determination of cytidine aminohydrolase activity in serum. | J Chromatogr | 1969 | https://conductscience.org/library/papers/4980116 | PubMed |
| 11 | 5,838,712 | Intertissue diffusion effect for inert fat-soluble gases. | J Appl Physiol | 1965 | https://conductscience.org/library/papers/5838712 | PubMed |
| 12 | 5,127,083 | Methotrexate pharmacokinetics. | J Pharm Sci | 1971 | https://conductscience.org/library/papers/5127083 | PubMed |
| 13 | 5,883,424 | Pharmacokinetic models regarding protein binding of drugs. | Antimicrob Agents Chemother (Bethesda) | 1965 | https://conductscience.org/library/papers/5883424 | PubMed |
| 14 | 5,459,901 | Energy metabolism, body size, and problems of scaling. | Fed Proc | 1970 | https://conductscience.org/library/papers/5459901 | PubMed |
| 16 | 14,145,385 | WHERE DOES THE PENTOTHAL GO? | Bull N Y Acad Med | 1964 | https://conductscience.org/library/papers/14145385 | PubMed |
| 17 | 5,905,061 | The effect of thiopental metabolism on duration of anesthesia. | Anesthesiology | 1966 | https://conductscience.org/library/papers/5905061 | PubMed |
| 18 | 5,411,973 | Mediated transport of chloride from blood into cerebrospinal fluid. | Exp Brain Res | 1970 | https://conductscience.org/library/papers/5411973 | PubMed |
| 19 | 5,651,639 | Mouse kidney cytidine deaminase. Purification and properties. | J Biol Chem | 1968 | https://conductscience.org/library/papers/5651639 | PubMed |
| 20 | 6,028,766 | Comparative pharmacology and cerebrospinal fluid. | Fed Proc | 1967 | https://conductscience.org/library/papers/6028766 | PubMed |
| 21 | 4,500,983 | In vitro-in vivo correlation of drug metabolism--deamination of 1- -D-arabinofuranosylcytosine. | Biochem Pharmacol | 1972 | https://conductscience.org/library/papers/4500983 | PubMed |
| 22 | 4,712,617 | Transport and binding of methotrexate in vivo. | J Pharm Sci | 1973 | https://conductscience.org/library/papers/4712617 | PubMed |
Cited by85
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 316 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,514,902 | Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514902 | PubMed |
| 42,176,251 | Breaking Barriers Between Species: Integrated Multi-Species PK Models Improve Human PK Predictions. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/42176251 | PubMed |
| 42,108,353 | Overview of Quantitative Clinical Pharmacology for T-Cell Engaging Bispecific Antibodies. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/42108353 | PubMed |
| 41,034,676 | Single- and Multiple-dose Pharmacokinetics, Excretion, Metabolism, and Safety of the Antivirulence Agent Fluorothiazinone in Healthy Adults. | Pharm Res | 2025 | https://conductscience.org/library/papers/41034676 | PubMed |
| 40,969,885 | Cross-Species Extrapolation of Neonatal Fc Receptor (FcRn) Binding Affinity to Predict Monoclonal Antibody Pharmacokinetics in Humans Using Physiologically Based Pharmacokinetic Modeling (PBPK): Are We There Yet? | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/40969885 | PubMed |
| 38,922,113 | Recent Progress on Physiologically Based Pharmacokinetic (PBPK) Model: A Review Based on Bibliometrics. | Toxics | 2024 | https://conductscience.org/library/papers/38922113 | PubMed |
| 37,530,974 | A Quantitative Prediction Method for the Human Pharmacokinetics of Fc-Fusion Proteins. | Eur J Drug Metab Pharmacokinet | 2023 | https://conductscience.org/library/papers/37530974 | PubMed |
| 37,242,468 | Application of the Population Pharmacokinetics Model-Based Approach to the Prediction of Drug-Drug Interaction between Rivaroxaban and Carbamazepine in Humans. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37242468 | PubMed |
| 36,839,666 | Scaling Pharmacodynamics from Rats to Humans to Support Erythropoietin and Romiplostim Combination Therapy to Treat Erythropoietin-Resistant Anemia. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36839666 | PubMed |
| 36,361,546 | Review of the Existing Translational Pharmacokinetics Modeling Approaches Specific to Monoclonal Antibodies (mAbs) to Support the First-In-Human (FIH) Dose Selection. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36361546 | PubMed |
| 35,735,361 | A Simple Method for the Prediction of Human Concentration-Time Profiles and Pharmacokinetics of Antibody-Drug Conjugates (ADC) from Rats or Monkeys. | Antibodies (Basel) | 2022 | https://conductscience.org/library/papers/35735361 | PubMed |
| 34,120,326 | Comparison of Various Approaches to Translate Non-Linear Pharmacokinetics of Monoclonal Antibodies from Cynomolgus Monkey to Human. | Eur J Drug Metab Pharmacokinet | 2021 | https://conductscience.org/library/papers/34120326 | PubMed |
| 32,182,820 | Application of an Inter-Species Extrapolation Method for the Prediction of Drug Interactions between Propolis and Duloxetine in Humans. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32182820 | PubMed |
| 31,115,997 | Prediction of Human Pharmacokinetics of Antibody-Drug Conjugates From Nonclinical Data. | Clin Transl Sci | 2019 | https://conductscience.org/library/papers/31115997 | PubMed |
| 31,068,073 | Retrospective analysis of model-based predictivity of human pharmacokinetics for anti-IL-36R monoclonal antibody MAB92 using a rat anti-mouse IL-36R monoclonal antibody and RNA expression data (FANTOM5). | MAbs | 2019 | https://conductscience.org/library/papers/31068073 | PubMed |
| 30,959,827 | Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling. | Pharmaceutics | 2019 | https://conductscience.org/library/papers/30959827 | PubMed |
| 30,298,434 | Tissue Physiology of Cynomolgus Monkeys: Cross-Species Comparison and Implications for Translational Pharmacology. | AAPS J | 2018 | https://conductscience.org/library/papers/30298434 | PubMed |
| 30,039,459 | Evaluation of Generic Methods to Predict Human Pharmacokinetics Using Physiologically Based Pharmacokinetic Model for Early Drug Discovery of Tyrosine Kinase Inhibitors. | Eur J Drug Metab Pharmacokinet | 2019 | https://conductscience.org/library/papers/30039459 | PubMed |
| 29,634,717 | Pharmacokinetics and interspecies scaling of a novel, orally-bioavailable anti-cancer drug, SHetA2. | PLoS One | 2018 | https://conductscience.org/library/papers/29634717 | PubMed |
| 29,351,372 | A Preclinical Population Pharmacokinetic Model for Anti-CD20/CD3 T-Cell-Dependent Bispecific Antibodies. | Clin Transl Sci | 2018 | https://conductscience.org/library/papers/29351372 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4787619
GET https://conductscience.org/api/papers/v1/4787619/references?page=2